- 2024-10-12 09:35HSP90/LSD1-IN-1
- 2024-10-12 09:35SARS-CoV-2-IN-96
- 2024-10-12 09:35KSRP-IN-1
- 2024-10-12 09:35Antimalarial agent 43
- 2024-10-12 09:35TS-002266
- 2024-10-12 09:35Enpp-1-IN-22
- 2024-10-12 09:35HDAC-IN-78
- 2024-10-12 09:35TS-002902
- 2024-10-12 09:34NODAGA-NHS
- 2024-10-12 09:34Neuroprotective agent 5
- 2024-10-12 09:34TRPV1/CB2 agonist 1
- 2024-10-12 09:34FLT3/HDAC-IN-2
- 2024-10-12 09:34VL285 Phenol-PEG2-Cl
- 2024-10-12 09:34AChE-IN-75
- 2024-10-12 09:34Antibiofilm agent-11
- 2024-10-12 09:34Lorvotuzumab mertansine
- 2024-10-12 09:34Antiproliferative agent-57
- 2024-10-12 09:34AChE-IN-76
- 2024-10-12 09:34HDAC-IN-79
- 2024-10-12 09:34MJBIA9836
